Editing Data Dictionary: European Health for All database (HFA-DB)

<span style="display:none">europeanunion</span>
Go back to [[Database: European Health for All database (HFA-DB) (European Union)]]

The following is a list of labels for variables. A complete data dictionary with all database metadata can be found with the downloadable dataset.

{| class="wikitable"
! Measure labels !!  !! 
|-
| Code || Label || 
|-
| HFA_1 || Mid-year population, by sex || 
|-
| HFA_2 || Mid-year male population || 
|-
| HFA_3 || Mid-year female population || 
|-
| HFA_10 || % of population aged 0–14 years, by sex || 
|-
| HFA_11 || % of population aged 0–14 years, males || 
|-
| HFA_12 || % of population aged 0–14 years, females || 
|-
| HFA_13 || % of population aged 65+ years, by sex || 
|-
| HFA_14 || % of population aged 65+ years, males || 
|-
| HFA_15 || % of population aged 65+ years, females || 
|-
| HFA_16 || Live births per 1000 population, by sex || 
|-
| HFA_17 || Live births per 1000 population, males || 
|-
| HFA_18 || Live births per 1000 population, females || 
|-
| HFA_19 || Number of live births, by sex || 
|-
| HFA_20 || Number of live births, males || 
|-
| HFA_21 || Number of live births, females || 
|-
| HFA_22 || Crude death rate per 1000 population, by sex || 
|-
| HFA_23 || Crude death rate per 1000 population, males || 
|-
| HFA_24 || Crude death rate per 1000 population, females || 
|-
| HFA_25 || Total fertility rate || 
|-
| HFA_26 || % of urban population || 
|-
| HFA_27 || Average population density per km2 || 
|-
| HFA_28 || Area (km2) || 
|-
| HFA_29 || Unemployment rate (%) || 
|-
| HFA_30 || Labour force as % of population || 
|-
| HFA_31 || Annual average rate of inflation (%) || 
|-
| HFA_32 || Gross national income, US$ per capita || 
|-
| HFA_33 || Gross domestic product (GDP), US$ per capita || 
|-
| HFA_34 || Real gross domestic product, purchasing power parity (USD) per capita || 
|-
| HFA_35 || Total government expenditure as % of GDP || 
|-
| HFA_36 || Literacy rate (%) in population aged 15+ years, by sex || 
|-
| HFA_37 || Literacy rate (%) in male population aged 15+ years || 
|-
| HFA_38 || Literacy rate (%) in female population aged 15+ years || 
|-
| HFA_39 || % of population with postsecondary education aged 25+ years || 
|-
| HFA_40 || % of population with primary education only aged 25+ years || 
|-
| HFA_41 || % of population with secondary education only aged 25+ years || 
|-
| HFA_42 || UNDP Human Development Index (HDI) || 
|-
| HFA_43 || Life expectancy at birth (years), by sex || 
|-
| HFA_44 || Life expectancy at birth (years), males || 
|-
| HFA_45 || Life expectancy at birth (years), females || 
|-
| HFA_46 || Life expectancy at age 1 (years), by sex || 
|-
| HFA_47 || Life expectancy at age 1 (years), males || 
|-
| HFA_48 || Life expectancy at age 1 (years), females || 
|-
| HFA_49 || Life expectancy at age 15 (years), by sex || 
|-
| HFA_50 || Life expectancy at age 15 (years), males || 
|-
| HFA_51 || Life expectancy at age 15 (years), females || 
|-
| HFA_52 || Life expectancy at age 45 (years), by sex || 
|-
| HFA_53 || Life expectancy at age 45 (years), males || 
|-
| HFA_54 || Life expectancy at age 45 (years), females || 
|-
| HFA_55 || Life expectancy at age 65 (years), by sex || 
|-
| HFA_56 || Life expectancy at age 65 (years), males || 
|-
| HFA_57 || Life expectancy at age 65 (years), females || 
|-
| HFA_58 || Reduction of life expectancy through death before 65 years, by sex || 
|-
| HFA_59 || Reduction of life expectancy through death before 65 years, males || 
|-
| HFA_60 || Reduction of life expectancy through death before 65 years, females || 
|-
| HFA_61 || Probability of dying before age 5 per 1000 live births, by sex || 
|-
| HFA_62 || Probability of dying before age 5 per 1000 live births, males || 
|-
| HFA_63 || Probability of dying before age 5 per 1000 live births, females || 
|-
| HFA_64 || Estimated probability of dying before age 5, per 1000 live births (world health report) || 
|-
| HFA_67 || Disability-adjusted life expectancy, by sex || 
|-
| HFA_68 || Disability-adjusted life expectancy, males || 
|-
| HFA_69 || Disability-adjusted life expectancy, females || 
|-
| HFA_70 || Estimated life expectancy at birth, by sex || 
|-
| HFA_71 || Estimated life expectancy at birth, males || 
|-
| HFA_72 || Estimated life expectancy at birth, females || 
|-
| HFA_73 || Estimated infant mortality per 1000 live births (world health report) || 
|-
| HFA_74 || Infant deaths per 1000 live births, by sex || 
|-
| HFA_75 || Infant deaths per 1000 live births, males || 
|-
| HFA_76 || Infant deaths per 1000 live births, females || 
|-
| HFA_77 || Neonatal deaths per 1000 live births || 
|-
| HFA_78 || Early neonatal deaths per 1000 live births || 
|-
| HFA_79 || Number of early neonatal deaths || 
|-
| HFA_80 || Late neonatal deaths per 1000 live births || 
|-
| HFA_81 || Postneonatal deaths per 1000 live births || 
|-
| HFA_82 || Fetal deaths per 1000 births || 
|-
| HFA_83 || Number of dead-born fetuses || 
|-
| HFA_84 || Perinatal deaths per 1000 births || 
|-
| HFA_85 || Number of deadborn fetuses with a birth weight of 1000 g or more || 
|-
| HFA_86 || Number of early neonatal deaths with a birth weight of 1000 g or more || 
|-
| HFA_87 || Number of live births with a birth weight of 1000 g or more || 
|-
| HFA_88 || Perinatal deaths national criteria per 1000 births || 
|-
| HFA_89 || Perinatal deaths 1000+g per 1000 births || 
|-
| HFA_90 || Maternal deaths per 100 000 live births, max of cod and clinical data || 
|-
| HFA_91 || Maternal deaths, abortion, per 100 000 live births || 
|-
| HFA_92 || Maternal deaths, haemorrhage, per 100 000 live births || 
|-
| HFA_93 || Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births || 
|-
| HFA_94 || Maternal deaths, puerperium, per 100 000 live births || 
|-
| HFA_95 || Maternal deaths per 100 000 live births according to clinical data || 
|-
| HFA_96 || Maternal deaths, cause of death data per 100 000 live births || 
|-
| HFA_97 || Estimated maternal mortality per 100 000 live births (WHO/UNICEFF/UNFPA estimates) || 
|-
| HFA_98 || Diseases of circulatory system, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_99 || Diseases of circulatory system, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_100 || Diseases of circulatory system, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_101 || Diseases of circulatory system, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_102 || Diseases of circulatory system, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_103 || Diseases of circulatory system, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_104 || Diseases of circulatory system, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_105 || Diseases of circulatory system, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_106 || Diseases of circulatory system, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_107 || Ischaemic heart disease, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_108 || Ischaemic heart disease, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_109 || Ischaemic heart disease, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_110 || Ischaemic heart disease, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_111 || Ischaemic heart disease, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_112 || Ischaemic heart disease, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_113 || Ischaemic heart disease, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_114 || Ischaemic heart disease, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_115 || Ischaemic heart disease, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_116 || Cerebrovascular diseases, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_117 || Cerebrovascular diseases, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_118 || Cerebrovascular diseases, 0–64, per 100 000,females (age-standardized death rate) || 
|-
| HFA_119 || Cerebrovascular diseases, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_120 || Cerebrovascular diseases, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_121 || Cerebrovascular diseases, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_122 || Cerebrovascular diseases, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_123 || Cerebrovascular diseases, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_124 || Cerebrovascular diseases, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_125 || Malignant neoplasms, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_126 || Malignant neoplasms, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_127 || Malignant neoplasms, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_128 || Malignant neoplasms, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_129 || Malignant neoplasms, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_130 || Malignant neoplasms, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_131 || Malignant neoplasms, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_132 || Malignant neoplasms, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_133 || Malignant neoplasms, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_134 || Trachea/bronchus/lung cancer, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_135 || Trachea/bronchus/lung cancer, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_136 || Trachea/bronchus/lung cancer, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_137 || Trachea/bronchus/lung cancer, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_138 || Trachea/bronchus/lung cancer, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_139 || Trachea/bronchus/lung cancer, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_140 || Trachea/bronchus/lung cancer, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_141 || Trachea/bronchus/lung cancer, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_142 || Trachea/bronchus/lung cancer, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_143 || Cancer of the cervix uteri, 0–64, per 100 000 (age-standardized death rate) || 
|-
| HFA_144 || Cancer of the cervix uteri, all ages, per 100 000 (age-standardized death rate) || 
|-
| HFA_145 || Cancer of the cervix uteri, 65+, per 100 000 (age-standardized death rate) || 
|-
| HFA_146 || Malignant neoplasm female breast, 0–64, per 100 000 (age-standardized death rate) || 
|-
| HFA_147 || Malignant neoplasm female breast, all ages, per 100 000 (age-standardized death rate) || 
|-
| HFA_148 || Malignant neoplasm female breast, 65+, per 100 000 (age-standardized death rate) || 
|-
| HFA_149 || External causes of injury and poisoning, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_150 || External causes of injury and poisoning, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_151 || External causes of injury and poisoning, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_152 || External causes of injury and poisoning, 0–4 (age-standardized death rate) || 
|-
| HFA_153 || External causes of injury and poisoning, 0–4, males (age-standardized death rate) || 
|-
| HFA_154 || External causes of injury and poisoning, 0–4, females (age-standardized death rate) || 
|-
| HFA_155 || External causes of injury and poisoning, 5–19 (age-standardized death rate) || 
|-
| HFA_156 || External causes of injury and poisoning, 5–19, males (age-standardized death rate) || 
|-
| HFA_157 || External causes of injury and poisoning, 5–19, females (age-standardized death rate) || 
|-
| HFA_158 || External causes of injury and poisoning, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_159 || External causes of injury and poisoning, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_160 || External causes of injury and poisoning, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_161 || External causes of injury and poisoning, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_162 || External causes of injury and poisoning, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_163 || External causes of injury and poisoning, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_164 || Motor vehicle traffic accidents, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_165 || Motor vehicle traffic accidents, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_166 || Motor vehicle traffic accidents, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_167 || Motor vehicle traffic accidents, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_168 || Motor vehicle traffic accidents, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_169 || Motor vehicle traffic accidents, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_170 || Motor vehicle traffic accidents, 65+, per 100 000, by sex0 (age-standardized death rate) || 
|-
| HFA_171 || Motor vehicle traffic accidents, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_172 || Motor vehicle traffic accidents, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_173 || Suicide and self-inflicted injury, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_174 || Suicide and self-inflicted injury, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_175 || Suicide and self-inflicted injury, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_176 || Suicide and self-inflicted injury, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_177 || Suicide and self-inflicted injury, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_178 || Suicide and self-inflicted injury, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_179 || Suicide and self-inflicted injury, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_180 || Suicide and self-inflicted injury, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_181 || Suicide and self-inflicted injury, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_182 || Homicide and intentional injury, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_183 || Homicide and intentional injury, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_184 || Homicide and intentional injury, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_185 || Homicide and intentional injury, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_186 || Homicide and intentional injury, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_187 || Homicide and intentional injury, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_188 || Homicide and intentional injury, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_189 || Homicide and intentional injury, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_190 || Homicide and intentional injury, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_191 || Transport accidents, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_192 || Transport accidents, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_193 || Transport accidents, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_194 || All causes, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_195 || All causes, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_196 || All causes, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_197 || All causes, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_198 || All causes, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_199 || All causes, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_200 || All causes, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_201 || All causes, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_202 || All causes, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_203 || Infectious and parasitic diseases, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_204 || Infectious and parasitic diseases, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_205 || Infectious and parasitic diseases, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_206 || Infectious and parasitic diseases, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_207 || Infectious and parasitic diseases, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_208 || Infectious and parasitic diseases, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_209 || Infectious and parasitic diseases, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_210 || Infectious and parasitic diseases, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_211 || Infectious and parasitic diseases, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_212 || Diseases of respiratory system, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_213 || Diseases of respiratory system, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_214 || Diseases of respiratory system, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_215 || Diseases of respiratory system, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_216 || Diseases of respiratory system, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_217 || Diseases of respiratory system, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_218 || Diseases of respiratory system, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_219 || Diseases of respiratory system, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_220 || Diseases of respiratory system, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_221 || Bronchitis/emphysema/asthma, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_222 || Bronchitis/emphysema/asthma, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_223 || Bronchitis/emphysema/asthma, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_224 || Bronchitis/emphysema/asthma, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_225 || Bronchitis/emphysema/asthma, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_226 || Bronchitis/emphysema/asthma, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_227 || Diseases of digestive system, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_228 || Diseases of digestive system, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_229 || Diseases of digestive system, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_230 || Diseases of digestive system, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_231 || Diseases of digestive system, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_232 || Diseases of digestive system, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_233 || Diseases of digestive system, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_234 || Diseases of digestive system, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_235 || Diseases of digestive system, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_236 || Chronic liver disease and cirrhosis, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_237 || Chronic liver disease and cirrhosis, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_238 || Chronic liver disease and cirrhosis, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_239 || Chronic liver disease and cirrhosis, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_240 || Chronic liver disease and cirrhosis, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_241 || Chronic liver disease and cirrhosis, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_242 || Endocrine, nutritional and metabolic diseases, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_243 || Endocrine/nutrition/metabolic disease/disorder involving immune mechanism, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_244 || Endocrine/nutrition/metabolic disease/disorder involving immune mechanism, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_245 || Endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_246 || Endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_247 || Endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_248 || Diabetes, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_249 || Diabetes mellitus, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_250 || Diabetes mellitus, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_251 || Diabetes mellitus, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_252 || Diabetes mellitus, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_253 || Diabetes mellitus, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_254 || Diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_255 || Diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_256 || Diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_257 || Diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_258 || Diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_259 || Diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_260 || Mental disorders, diseases of nervous system and sense organs, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_261 || Mental disorders, diseases of nervous system and sense organs, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_262 || Mental disorders, diseases of nervous system and sense organs, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_263 || Mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_264 || Mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_265 || Mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_266 || Mental disorders, diseases of nervous system and sense organs, 65+/100 000 (age-standardized death rate) || 
|-
| HFA_267 || Mental disorders, diseases of nervous system and sense organs, 65+/100 000, males (age-standardized death rate) || 
|-
| HFA_268 || Mental disorders, diseases of nervous system and sense organs, 65+/100 000, females (age-standardized death rate) || 
|-
| HFA_269 || Disease of genitourinary system, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_270 || Disease of genitourinary system, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_271 || Disease of genitourinary system, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_272 || Disease of genitourinary system, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_273 || Disease of genitourinary system, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_274 || Disease of genitourinary system, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_275 || Symptoms, signs and ill-defined conditions, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_276 || Symptoms, signs and ill defined conditions, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_277 || Symptoms, signs and ill defined conditions, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_278 || Symptoms, signs and ill defined conditions, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_279 || Symptoms, signs and ill defined conditions, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_280 || Symptoms, signs and ill defined conditions, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_281 || Symptoms, signs and ill defined conditions, 65+, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_282 || Symptoms, signs and ill defined conditions, 65+, per 100 000, males (age-standardized death rate) || 
|-
| HFA_283 || Symptoms, signs and ill defined conditions, 65+, per 100 000, females (age-standardized death rate) || 
|-
| HFA_284 || Tuberculosis, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_285 || Tuberculosis, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_286 || Tuberculosis, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_287 || Diarrhoeal diseases, under 5 years, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_288 || Diarrhoeal diseases, under 5 years, per 100 000, males (age-standardized death rate) || 
|-
| HFA_289 || Diarrhoeal diseases, under 5 years, per 100 000, females (age-standardized death rate) || 
|-
| HFA_290 || Acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_291 || Acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000, males (age-standardized death rate) || 
|-
| HFA_292 || Acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000, females (age-standardized death rate) || 
|-
| HFA_293 || Selected alcohol-related causes, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_294 || Selected alcohol-related causes, per 100 000, males (age-standardized death rate) || 
|-
| HFA_295 || Selected alcohol-related causes, per 100 000, females (age-standardized death rate) || 
|-
| HFA_296 || Selected smoking-related causes, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_297 || Selected smoking-related causes, per 100 000, males (age-standardized death rate) || 
|-
| HFA_298 || Selected smoking-related causes, per 100 000, females (age-standardized death rate) || 
|-
| HFA_299 || Major non-communicable diseases, 30-69 years, by sex (age-standardized death rate) || 
|-
| HFA_300 || Major noncommunicable diseases, 30-69 years, males (age-standardized death rate) || 
|-
| HFA_301 || Major noncommunicable diseases, 30-69 years, females (age-standardized death rate) || 
|-
| HFA_302 || Digestive diseases, 30-69 years, by sex (age-standardized death rate) || 
|-
| HFA_303 || Digestive diseases, 30-69 years, males (age-standardized death rate) || 
|-
| HFA_304 || Digestive diseases, 30-69 years, females (age-standardized death rate) || 
|-
| HFA_305 || Incidence of tuberculosis per 100 000 || 
|-
| HFA_306 || Number of new tuberculosis cases || 
|-
| HFA_307 || Estimated incidence of tuberculosis per 100 000 || 
|-
| HFA_308 || Estimated prevalence of tuberculosis per 100 000 || 
|-
| HFA_309 || Estimated mortality of tuberculosis per 100 000 || 
|-
| HFA_310 || Proportion (%) of tuberculosis cases detected under DOTS || 
|-
| HFA_311 || Proportion (%) of tuberculosis cases cured under DOTS || 
|-
| HFA_312 || Incidence of viral hepatitis per 100 000 || 
|-
| HFA_313 || Number of new viral hepatitis cases || 
|-
| HFA_314 || Number of new hepatitis C cases || 
|-
| HFA_315 || Incidence of hepatitis C per 100 000 || 
|-
| HFA_316 || Incidence of viral hepatitis A per 100 000 || 
|-
| HFA_317 || Number of new hepatitis A cases || 
|-
| HFA_318 || Incidence of viral hepatitis B per 100 000 || 
|-
| HFA_319 || Number of new hepatitis B cases || 
|-
| HFA_320 || Incidence of syphilis per 100 000 || 
|-
| HFA_321 || Number of new syphilis cases || 
|-
| HFA_322 || Incidence of gonococcal infection per 100 000 || 
|-
| HFA_323 || Number of new gonococcal infection cases || 
|-
| HFA_324 || Incidence of pertussis per 100 000 || 
|-
| HFA_325 || Number of new pertussis cases || 
|-
| HFA_326 || Incidence of measles per 100 000 || 
|-
| HFA_327 || Number of new measles cases || 
|-
| HFA_328 || Incidence of malaria per 100 000 || 
|-
| HFA_329 || Number of new malaria cases || 
|-
| HFA_330 || Number of deaths from malaria || 
|-
| HFA_331 || Incidence of diphtheria per 100 000 || 
|-
| HFA_332 || Number of new diphtheria cases || 
|-
| HFA_333 || Incidence of tetanus per 100 000 || 
|-
| HFA_334 || Number of new tetanus cases || 
|-
| HFA_335 || Incidence of acute poliomyelitis per 100 000 || 
|-
| HFA_336 || Number of new poliomyelitis cases || 
|-
| HFA_337 || Incidence of congenital syphilis per 100 000 || 
|-
| HFA_338 || Number of new congenital syphilis cases || 
|-
| HFA_339 || Incidence of congenital rubella per 100 000 || 
|-
| HFA_340 || Number of new congenital rubella cases || 
|-
| HFA_341 || Incidence of neonatal tetanus per 100 000 || 
|-
| HFA_342 || Number of new neonatal tetanus cases || 
|-
| HFA_343 || Incidence of rubella per 100 000 || 
|-
| HFA_344 || Number of new rubella cases || 
|-
| HFA_345 || Incidence of mumps per 100 000 || 
|-
| HFA_346 || Number of new mumps cases || 
|-
| HFA_347 || Rate of new AIDS cases per 100 000 || 
|-
| HFA_348 || Number of new AIDS cases || 
|-
| HFA_349 || Rate of new HIV diagnoses per 100 000 || 
|-
| HFA_350 || Number of new HIV diagnoses || 
|-
| HFA_351 || Incidence of Haemophilus influenzae type b invasive disease per 100 000 || 
|-
| HFA_352 || Number of new Haemophilus influenzae type b invasive disease cases || 
|-
| HFA_353 || Hospital discharges, infectious and parasitic diseases per 100 000 || 
|-
| HFA_354 || Hospital discharges, infectious and parasitic diseases || 
|-
| HFA_355 || Hospital discharges, all neoplasms per 100 000 || 
|-
| HFA_356 || Hospital discharges, all neoplasms || 
|-
| HFA_357 || Incidence of cancer per 100 000, by sex || 
|-
| HFA_358 || Number of new cases of cancer, by sex || 
|-
| HFA_359 || Number of new cases of cancer, males || 
|-
| HFA_360 || Number of new cases of cancer, females || 
|-
| HFA_361 || Incidence of cancer per 100 000, males || 
|-
| HFA_362 || Incidence of cancer per 100 000, female || 
|-
| HFA_363 || Prevalence of cancer (%), by sex || 
|-
| HFA_364 || Number of all cases of cancer at year's end, by sex || 
|-
| HFA_365 || Number of all cases cancer at year's end, males || 
|-
| HFA_366 || Number of all cases cancer at year's end, females || 
|-
| HFA_367 || Prevalence of cancer (%), males || 
|-
| HFA_368 || Prevalence of cancer (%), females || 
|-
| HFA_369 || Incidence of trachea, bronchus and lung cancer per 100 000, by sex || 
|-
| HFA_370 || Number of new cases of trachea, bronchus and lung cancer, by sex || 
|-
| HFA_371 || Number of new cases of trachea, bronchus and lung cancer, males || 
|-
| HFA_372 || Number of new cases of trachea, bronchus and lung cancer, females || 
|-
| HFA_373 || Incidence of trachea, bronchus and lung cancer per 100 000, males || 
|-
| HFA_374 || Incidence of trachea, bronchus and lung cancer per 100 000, females || 
|-
| HFA_375 || Incidence of female breast cancer per 100 000 || 
|-
| HFA_376 || Number of new cases of female breast cancer || 
|-
| HFA_377 || Incidence of cervix uteri cancer per 100 000 || 
|-
| HFA_378 || Number of new cases of cervix uteri cancer || 
|-
| HFA_379 || Prevalence of diabetes mellitus (%) || 
|-
| HFA_380 || Number of all cases of diabetes mellitus at year's end || 
|-
| HFA_381 || Number of new cases of diabetes mellitus || 
|-
| HFA_382 || New cases, diabetes mellitus per 100 000 || 
|-
| HFA_383 || Number of mental patients staying in hospitals 365+ days per 100 000 || 
|-
| HFA_384 || Number of mental patients staying in hospitals 365+ days || 
|-
| HFA_385 || Number of hospital discharges, mental and behavioural disorders || 
|-
| HFA_386 || Hospital discharges, mental and behavioural disorders, per 100 000 || 
|-
| HFA_387 || Incidence of mental disorders per 100 000 || 
|-
| HFA_388 || Number of new cases of mental disorders || 
|-
| HFA_389 || Incidence of alcoholic psychosis per 100 000 || 
|-
| HFA_390 || Number of new cases of alcoholic psychosis || 
|-
| HFA_391 || Prevalence of mental disorders (%) || 
|-
| HFA_392 || All cases of mental disorders at year's end || 
|-
| HFA_393 || Hospital discharges, circulatory system disease, per 100 000 || 
|-
| HFA_394 || Number of hospital discharges, circulatory system disease || 
|-
| HFA_395 || Hospital discharges, ischaemic heart disease, per 100 000 || 
|-
| HFA_396 || Number of hospital discharges, ischaemic heart disease || 
|-
| HFA_398 || Hospital discharges, cerebrovascular diseases, per 100 000 || 
|-
| HFA_399 || Hospital discharges, cerebrovascular diseases || 
|-
| HFA_401 || Hospital discharges, respiratory system diseases, per 100 000 || 
|-
| HFA_402 || Hospital discharges, respiratory system diseases || 
|-
| HFA_403 || Prevalence of chronic obstructive pulmonary disease (%) || 
|-
| HFA_404 || Number of cases of chronic obstructive pulmonary disease || 
|-
| HFA_405 || Hospital discharges, digestive system diseases, per 100 000 || 
|-
| HFA_406 || Hospital discharges, digestive system diseases || 
|-
| HFA_407 || Hospital discharges, musculoskeletal system and connective tissue diseases, per 100 000 || 
|-
| HFA_408 || Hospital discharges, musculoskeletal system and connective tissue diseases || 
|-
| HFA_409 || Hospital discharges, injury and poisoning, per 100 000 || 
|-
| HFA_410 || Hospital discharges, injury and poisoning || 
|-
| HFA_411 || Absenteeism from work due to illness, days per employee per year || 
|-
| HFA_412 || New invalidity/disability cases per 100 000 || 
|-
| HFA_413 || Number of newly recognized invalidity/disability cases || 
|-
| HFA_414 || People receiving social/disability benefits per 100 000 || 
|-
| HFA_415 || Number of people receiving social/disability benefits || 
|-
| HFA_416 || % of disabled people of working age engaged in regular occupational activity || 
|-
| HFA_417 || % population self-assessing health as good, by sex || 
|-
| HFA_418 || % population self-assessing health as good, males || 
|-
| HFA_419 || % population self-assessing health as good, females || 
|-
| HFA_421 || % of regular daily smokers in the population, age 15+, by sex || 
|-
| HFA_422 || % of regular daily smokers in the population, age 15+, males || 
|-
| HFA_423 || % of regular daily smokers in the population, age 15+, females || 
|-
| HFA_426 || Pure alcohol consumption, litres per capita, age 15+ || 
|-
| HFA_427 || Spirits consumed in pure alcohol, litres per capita, age 15+ || 
|-
| HFA_428 || Wine consumed in pure alcohol, litres per capita, age 15+ || 
|-
| HFA_429 || Beer consumed in pure alcohol, litres per capita, age 15+ || 
|-
| HFA_431 || Road traffic accidents involving alcohol per 100 000 || 
|-
| HFA_432 || Number of road traffic accidents involving alcohol || 
|-
| HFA_433 || First admissions to drug treatment centres per 100 000 || 
|-
| HFA_434 || Number of first admissions to drug treatment centres || 
|-
| HFA_436 || Road traffic accidents with injury per 100 000 || 
|-
| HFA_437 || Number of road traffic accidents with injury || 
|-
| HFA_438 || People killed or injured in road traffic accidents per 100 000 || 
|-
| HFA_439 || Number of people killed or injured in road traffic accidents || 
|-
| HFA_440 || Average number of calories available per person per day (kcal) || 
|-
| HFA_441 || % of total energy available from fat || 
|-
| HFA_442 || Fat available per person per day (g) || 
|-
| HFA_443 || % of total energy available from protein || 
|-
| HFA_444 || Protein available per person per day (g) || 
|-
| HFA_445 || Average amount of cereal available per person per year (kg) || 
|-
| HFA_446 || Average amount of fruits and vegetables available per person per year (kg) || 
|-
| HFA_447 || Microbiological foodborne diseases, number of outbreaks || 
|-
| HFA_448 || Microbiological foodborne diseases per 100 000 || 
|-
| HFA_449 || Number of cases of microbiological foodborne diseases || 
|-
| HFA_450 || Salmonellosis cases per 100 000 || 
|-
| HFA_451 || Number of salmonellosis cases || 
|-
| HFA_452 || New cases of occupational diseases per 100 000 || 
|-
| HFA_453 || Number of new cases of occupational diseases || 
|-
| HFA_454 || People injured due to work-related accidents per 100 000 || 
|-
| HFA_455 || Number of people injured due to work-related accidents || 
|-
| HFA_456 || Deaths due to work-related accidents per 100 000 || 
|-
| HFA_457 || Number of deaths due to work-related accidents || 
|-
| HFA_463 || % population with homes connected to water supply system, by place of residence || 
|-
| HFA_464 || % population with homes connected to water supply system, urban || 
|-
| HFA_465 || % population with homes connected to water supply system, rural || 
|-
| HFA_466 || % population with access to sewage system, septic tank or other hygienic means of sewage disposal, by place of residence || 
|-
| HFA_467 || % population with access to sewage system, septic tank or other hygienic means of sewage disposal, urban || 
|-
| HFA_468 || % population with access to sewage system, septic tank or other hygienic means of sewage disposal, rural || 
|-
| HFA_469 || Average number of people per room in occupied housing unit || 
|-
| HFA_470 || Hospitals per 100 000 || 
|-
| HFA_471 || Number of hospitals || 
|-
| HFA_472 || Acute (short-stay) hospitals per 100 000 || 
|-
| HFA_473 || Number of acute (short-stay) hospitals || 
|-
| HFA_474 || Primary health care units per 100 000 || 
|-
| HFA_475 || Number of primary health care units || 
|-
| HFA_476 || Hospital beds per 100 000 || 
|-
| HFA_477 || Total number of hospital beds || 
|-
| HFA_478 || Acute care hospital beds per 100 000 || 
|-
| HFA_479 || Number of acute care hospital beds || 
|-
| HFA_480 || Acute care hospital beds, medical group of specialties || 
|-
| HFA_481 || Acute care hospital beds, medical group of specialties, per 100 000 || 
|-
| HFA_482 || Acute care hospital beds, surgical group of specialties || 
|-
| HFA_483 || Acute care hospital beds, surgical group of specialties, per 100 000 || 
|-
| HFA_484 || Acute care hospital beds, obstetric and gynaecological group of specialties || 
|-
| HFA_485 || Acute care hospital beds, obstetric and gynaecological group of specialties, per 100 000 || 
|-
| HFA_486 || Acute care hospital beds, paediatric group of specialties || 
|-
| HFA_487 || Acute care hospital beds, paediatric group of specialties, per 100 000 || 
|-
| HFA_488 || Psychiatric hospital beds per 100 000 || 
|-
| HFA_489 || Number of psychiatric hospital beds || 
|-
| HFA_490 || Nursing and elderly home beds per 100 000 || 
|-
| HFA_491 || Number of nursing and elderly home beds || 
|-
| HFA_492 || Private inpatient hospital beds as % of all beds || 
|-
| HFA_493 || Number of private inpatient hospital beds || 
|-
| HFA_494 || Physicians per 100 000 || 
|-
| HFA_495 || Number of physicians, physical persons (physical persons) || 
|-
| HFA_496 || Physicians, (full-time equivalent) per 100 000 || 
|-
| HFA_497 || Number of physicians, (full-time equivalent) || 
|-
| HFA_498 || Physicians, medical group of specialties (physical persons), per 100 000 || 
|-
| HFA_499 || Number of physicians, medical group of specialties (physical persons) || 
|-
| HFA_500 || Number of physicians, surgical group of specialties (physical persons) || 
|-
| HFA_501 || Physicians, surgical group of specialties (physical persons), per 100 000 || 
|-
| HFA_502 || Number of physicians, obstetric and gynaecological group of specialties (physical persons) || 
|-
| HFA_503 || Physicians, obstetric and gynaecological group of specialties (physical persons), per 100 000 || 
|-
| HFA_504 || Number of physicians, paediatric specialties (physical persons) || 
|-
| HFA_505 || Physicians, paediatric group of specialties (physical persons), per 100 000 || 
|-
| HFA_506 || % of physicians working in hospitals || 
|-
| HFA_507 || General practitioners (physical persons) per 100 000 || 
|-
| HFA_508 || Number of general practitioners (physical persons) || 
|-
| HFA_509 || Dentists (physical persons) per 100 000 || 
|-
| HFA_510 || Number of dentists (physical persons) || 
|-
| HFA_511 || Dentists (full time equivalent) per 100 000 || 
|-
| HFA_512 || Number of dentists (full time equivalent) || 
|-
| HFA_513 || Pharmacists (physical persons) per 100 000 || 
|-
| HFA_514 || Number of pharmacists (physical persons) || 
|-
| HFA_515 || Nurses (physical persons) per 100 000 || 
|-
| HFA_516 || Number of nurses (physical persons) || 
|-
| HFA_517 || Nurses (full time equivalent) per 100 000 || 
|-
| HFA_518 || Number of nurses (full time equivalent) || 
|-
| HFA_519 || % of nurses working in hospitals || 
|-
| HFA_520 || Midwives (physical persons) per 100 000 || 
|-
| HFA_521 || Number of midwives (physical persons) || 
|-
| HFA_522 || Midwives (full time equivalent) per 100 000 || 
|-
| HFA_523 || Number of midwives (full time equivalent) || 
|-
| HFA_524 || Physicians graduated per 100 000 || 
|-
| HFA_525 || Number of physicians graduated in given year || 
|-
| HFA_526 || Nurses graduated per 100 000 || 
|-
| HFA_527 || Number of nurses graduated in given year || 
|-
| HFA_528 || Midwives graduated per 100 000 || 
|-
| HFA_529 || Number of midwives graduated in given year || 
|-
| HFA_530 || Pharmacists graduated per 100 000 || 
|-
| HFA_531 || Number of pharmacists graduated in given year || 
|-
| HFA_532 || Dentists graduated per 100 000 || 
|-
| HFA_533 || Number of dentists graduated in given year || 
|-
| HFA_534 || Inpatient care discharges per 100 || 
|-
| HFA_535 || Number of all hospital discharges || 
|-
| HFA_536 || Acute care hospital discharges per 100 || 
|-
| HFA_537 || Number of acute care hospital discharges || 
|-
| HFA_538 || Inpatient surgical procedures per year per 100 000 || 
|-
| HFA_539 || Total number of inpatient surgical procedures per year || 
|-
| HFA_540 || Average length of stay, all hospitals || 
|-
| HFA_541 || Average length of stay, acute care hospitals only || 
|-
| HFA_542 || Bed occupancy rate (%), acute care hospitals only || 
|-
| HFA_543 || Outpatient contacts per person per year || 
|-
| HFA_544 || Autopsy rate (%) for hospital deaths || 
|-
| HFA_545 || Autopsy rate (%) for all deaths || 
|-
| HFA_546 || Surgical wound infection rate (%), all operations || 
|-
| HFA_547 || Appendicitis, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_548 || Appendicitis, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_549 || Appendicitis, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_550 || Appendicitis, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_551 || Appendicitis, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_552 || Appendicitis, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_553 || Hernia and intestinal obstruction, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_554 || Hernia and intestinal obstruction, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_555 || Hernia and intestinal obstruction, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_556 || Hernia and intestinal obstruction, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_557 || Hernia and intestinal obstruction, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_558 || Hernia and intestinal obstruction, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_559 || Adverse effects of therapeutic agents, 0–64, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_560 || Adverse effects of therapeutic agents, 0–64, per 100 000, males (age-standardized death rate) || 
|-
| HFA_561 || Adverse effects of therapeutic agents, 0–64, per 100 000, females (age-standardized death rate) || 
|-
| HFA_562 || Adverse effects of therapeutic agents, all ages, per 100 000, by sex (age-standardized death rate) || 
|-
| HFA_563 || Adverse effects of therapeutic agents, all ages, per 100 000, males (age-standardized death rate) || 
|-
| HFA_564 || Adverse effects of therapeutic agents, all ages, per 100 000, females (age-standardized death rate) || 
|-
| HFA_565 || Total health expenditure as % of GDP, WHO estimates || 
|-
| HFA_566 || Total health expenditure as % of GDP || 
|-
| HFA_567 || Public-sector expenditure on health as % of GDP, WHO estimates || 
|-
| HFA_568 || Private-sector expenditure on health as % of GDP, WHO estimates || 
|-
| HFA_569 || Total health expenditure, purchasing power parity (USD) per capita, WHO estimates || 
|-
| HFA_570 || Total health expenditure, purchasing power parity (USD) per capita || 
|-
| HFA_571 || Public expenditure on health, purchasing power parity (USD) per capita, WHO estimates || 
|-
| HFA_572 || Public-sector health expenditure as % of total health expenditure, WHO estimates || 
|-
| HFA_573 || Public-sector health expenditure as % of total health expenditure || 
|-
| HFA_574 || Private-sector expenditure on health as % of total health expenditure, WHO estimates || 
|-
| HFA_575 || Total inpatient expenditure as % of total health expenditure || 
|-
| HFA_577 || Public inpatient expenditure as % of total inpatient expenditure || 
|-
| HFA_578 || Total pharmaceutical expenditure as % of total health expenditure || 
|-
| HFA_580 || Public pharmaceutical expenditure as % of total pharmaceutical expenditure || 
|-
| HFA_581 || Total capital investment expenditure on medical facilities as % of total health expenditure || 
|-
| HFA_582 || Salaries as % of total public health expenditure || 
|-
| HFA_583 || Public-sector expenditure on health as % of total government expenditure, WHO estimates || 
|-
| HFA_584 || Private households' out-of-pocket payments on health as % of total health expenditure || 
|-
| HFA_585 || Private households' out-of-pocket payments on health as % of private-sector health expenditure || 
|-
| HFA_586 || Abortions per 1000 live births || 
|-
| HFA_587 || Number of abortions, all ages || 
|-
| HFA_588 || Abortions per 1000 live births, age under 20 years || 
|-
| HFA_589 || Number of abortions, age under 20 years || 
|-
| HFA_590 || Abortions per 1000 live births, age 35+ years || 
|-
| HFA_591 || Number of abortions, age 35+ years || 
|-
| HFA_592 || % of all live births to mothers aged under 20 years || 
|-
| HFA_593 || Number of all live births to mothers aged under 20 years || 
|-
| HFA_594 || % of all live births to mothers aged 35+ years || 
|-
| HFA_595 || Number of all live births, mothers aged 35+ years || 
|-
| HFA_596 || Caesarean sections per 1000 live births || 
|-
| HFA_597 || Number of caesarean sections || 
|-
| HFA_598 || Proportion (%) of births attended by skilled health personnel || 
|-
| HFA_599 || Contraceptive use among currently married women aged 15–49 (%), any method || 
|-
| HFA_600 || % of live births weighing 2500 g or more || 
|-
| HFA_601 || Congenital anomalies per 100 000 live births || 
|-
| HFA_602 || Number of births with congenital anomalies || 
|-
| HFA_603 || Births with Down's syndrome per 100 000 live births || 
|-
| HFA_604 || Number of births with Down's syndrome || 
|-
| HFA_605 || % of infants vaccinated against tuberculosis || 
|-
| HFA_606 || % of infants vaccinated against diphtheria || 
|-
| HFA_607 || % of infants vaccinated against tetanus || 
|-
| HFA_608 || % of infants vaccinated against pertussis || 
|-
| HFA_609 || % of children vaccinated against measles || 
|-
| HFA_610 || % of infants vaccinated against poliomyelitis || 
|-
| HFA_611 || % infants vaccinated against invasive disease due to Haemophilus influenzae type b || 
|-
| HFA_612 || % of infants vaccinated against hepatitis B || 
|-
| HFA_613 || % of infants vaccinated against mumps || 
|-
| HFA_614 || % of infants vaccinated against rubella || 
|-
| HFA_615 || % of infants breastfed at age 3 months || 
|-
| HFA_616 || % of infants breastfed at age 6 months || 
|-
| HFA_617 || GINI coefficient (income distribution) || 
|-
| HFA_618 || Proportion of children of official primary school age not enrolled, by sex || 
|-
| HFA_619 || Proportion of children of official primary school age not enrolled, males || 
|-
| HFA_620 || Proportion of children of official primary school age not enrolled, females || 
|-
| HFA_621 || Availability of social support || 
|-
| HFA_622 || Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%), by sex || 
|-
| HFA_623 || Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%), males || 
|-
| HFA_624 || Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%), females || 
|-
| HFA_625 || Number cigarettes consumed per person per year || 
|-
| HFA_626 || Total number of cigarettes consumed (in million pieces), per year || 
|-
| HFA_627 || Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%), by sex || 
|-
| HFA_628 || Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%), males || 
|-
| HFA_629 || Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%), females || 
|-
| HFA_630 || Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%), by sex || 
|-
| HFA_631 || Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%), males || 
|-
| HFA_632 || Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%), females || 
|-
| HFA_633 || WHO Member States participating in the European Health Information Initiative (EHII) || 
|-
| HFA_634 || Healthy life expectancy (HALE ) at birth, female || 
|-
| HFA_635 || Healthy life expectancy (HALE) at birth, male || 
|-
| HFA_636 || Healthy life expectancy (HALE) at birth || 
|-
| HFA_637 || Youth unemployment rate, % of total labor force ages 15-25 || 
|-
| HFA_638 || Youth unemployment rate, % of labor force ages 15-24, female || 
|-
| HFA_639 || Youth unemployment rate, % of labor force ages 15-24, male || 
|-
| HFA_640 || Number of maternal deaths, clinical data || 
|-
|  ||  || 
|-
| Measure related labels ||  || 
|-
| UNIT_TYPE || Unit || 
|-
| NUM_PERS || number of persons || 
|-
| PERCENT || % || 
|-
| BIRTHS_1000 || births per 1000 population || 
|-
| NUM_BIRTHS || number of births || 
|-
| DTH_1000 || deaths per 1000 population || 
|-
| BIRTHS_WOMAN || births per woman || 
|-
| PERS_KM2 || persons per km2 || 
|-
| KM2 || km2 || 
|-
| USD_PER_CAPITA || US$ per capita || 
|-
| PPP_PER_CAPIT || PPP$ per capita || 
|-
| SCORE || score || 
|-
| YEARS || years || 
|-
| DTH_1000LBRTH || deaths per 1000 live births || 
|-
| NUM_DTH || number of deaths || 
|-
| DTH_1000BRTH || deaths per 1000 births || 
|-
| NUM_FETUSES || number of fetuses || 
|-
| DTH_100K_LBRTH || deaths per 100 000 live births || 
|-
| DTH_100K || deaths per 100 000 || 
|-
| CASES_100K || cases per 100 000 population || 
|-
| NUM_CASES || number of cases || 
|-
| DISCHARGES_100K || hospital discharges per 100 000 persons || 
|-
| NUM_DISCHARGES || number of hospital discharges || 
|-
| NUM_PATIENTS || number of patients || 
|-
| DAYS_PEMP_PYEAR || days per employee per year || 
|-
| PERS_100K || persons per 100 000 population || 
|-
| LITRES_PCAPITA || litres per capita || 
|-
| ACCIDENTS_100K || accidents per 100 000 population || 
|-
| NUM_ACCIDENTS || number of accidents || 
|-
| ADM_100K || admissions per 100 000 population || 
|-
| NUM_ADMISSIONS || number of admissions || 
|-
| KCAL_PPERS || kcal per person per day || 
|-
| GRAMM_PPERS_PDAY || grammes per person per day || 
|-
| KG_PPERS_PYEAR || kilograms per person per year || 
|-
| NUM_OUTBREAKS || number of outbreaks || 
|-
| FACIL_100K || facilities per 100 000 population || 
|-
| NUM_FACIL || number of facilities || 
|-
| BEDS_100K || beds per 100 000 population || 
|-
| NUM_BEDS || number of beds || 
|-
| PROFESS_100K || health professionals per 100 000 population || 
|-
| NUM_PROFESS || number of professionals || 
|-
| DISCHARGES_100POP || hospital discharges per 100 persons || 
|-
| PROC_100K || procedures per 100 000 population || 
|-
| NUM_PROC || number of procedures || 
|-
| NUM_DAYS || number of days || 
|-
| CONTACTS_PERS || contacts per person || 
|-
| PROC_1000LBIRTH || procedures per 1000 live births || 
|-
| NUM_LBIRTH || number of live births || 
|-
| NUM_100K_LBIRTH || number per 100 000 live births || 
|-
| NUM_CIG_PPERS || number of cigarettes per person || 
|-
| NUM_CIG_MIO_PCS || million pieces of cigarettes || 
|-
| NUM_RESPONSES || number of responses || 
|-
|  ||  || 
|-
| EXTERNID || ID in the originating data source || 
|-
|  ||  || 
|-
| DATA_SOURCE || Data source || 
|-
| HFA || European Health for All database || 
|-
|  ||  || 
|-
| DATA_TYPE_REPRESENTATION || Data type representation || 
|-
| COUNT || Count || 
|-
| RATIO || Ratio || 
|-
| SCORE || Score || 
|-
| RATE || Rate || 
|-
| CATEGORICAL || Categorical || 
|-
|  ||  || 
|-
| DATA_SET || Data set || 
|-
| HFA || European Health for All database (WHO) || 
|-
| CAH || Child and Adolescent Health and Development Strategy Indicators || 
|-
| HFAMDB || European mortality database (MDB) || 
|-
| JMF || Joint Monitoring Framework (JMF) || 
|-
|  ||  || 
|-
| DATA_MASK || Mask for controlling the output format of values || 
|-
|  ||  || 
|-
| Fact-attribute labels ||  || 
|-
| Code || Alias || Label
|-
| COUNTRY || COUNTRY_REGION || Country
|-
| COUNTRY_GRP || COUNTRY_REGION || Supranational group of countries
|-
| SEX ||  || Sex
|-
| YEAR ||  || Year of measure
|-
| PLACE_RESIDENCE ||  || Type of population (urban or rural)
|-
| YES_NO_UNK || YES_NO || Yes, No, Unknown
|-
|  ||  || 
|-
| Fact-attribute coded list labels ||  || 
|-
| Attribute code || Coded value || Label
|-
| SEX || FEMALE || Female
|-
| SEX || MALE || Male
|-
| SEX || ALL || All
|-
| PLACE_RESIDENCE || URBAN || Urban
|-
| PLACE_RESIDENCE || RURAL || Rural
|-
| PLACE_RESIDENCE || TOTAL || Total
|-
| YES_NO_UNK || YES || Yes
|-
| YES_NO_UNK || NO || No
|-
| YES_NO_UNK || UNK || Unknown
|-
| YES_NO_UNK || NORESP || No response
|-
| YES_NO_UNK || DNP || Did not participate in survey
|}